nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—CYP26A1—embryo—muscle cancer	0.0332	0.0987	CbGeAlD
Acitretin—RBP1—embryo—muscle cancer	0.0199	0.0589	CbGeAlD
Acitretin—RBP1—smooth muscle tissue—muscle cancer	0.0156	0.0463	CbGeAlD
Acitretin—RXRA—renal system—muscle cancer	0.0155	0.046	CbGeAlD
Acitretin—RBP1—renal system—muscle cancer	0.015	0.0446	CbGeAlD
Acitretin—RBP1—cardiac atrium—muscle cancer	0.0135	0.04	CbGeAlD
Acitretin—RXRB—cardiac atrium—muscle cancer	0.0114	0.034	CbGeAlD
Acitretin—RBP1—vagina—muscle cancer	0.0109	0.0323	CbGeAlD
Acitretin—RARB—tendon—muscle cancer	0.0109	0.0322	CbGeAlD
Acitretin—RARA—renal system—muscle cancer	0.0107	0.0317	CbGeAlD
Acitretin—RXRG—tendon—muscle cancer	0.0106	0.0315	CbGeAlD
Acitretin—RXRA—head—muscle cancer	0.0104	0.0307	CbGeAlD
Acitretin—RARB—vagina—muscle cancer	0.0101	0.0299	CbGeAlD
Acitretin—RBP1—head—muscle cancer	0.0101	0.0299	CbGeAlD
Acitretin—RXRB—tendon—muscle cancer	0.00997	0.0296	CbGeAlD
Acitretin—RBP1—testis—muscle cancer	0.00971	0.0288	CbGeAlD
Acitretin—RARB—head—muscle cancer	0.0093	0.0276	CbGeAlD
Acitretin—RXRB—vagina—muscle cancer	0.00925	0.0275	CbGeAlD
Acitretin—RXRG—head—muscle cancer	0.00909	0.027	CbGeAlD
Acitretin—RARG—tendon—muscle cancer	0.00885	0.0263	CbGeAlD
Acitretin—RXRG—testis—muscle cancer	0.00878	0.0261	CbGeAlD
Acitretin—RXRB—head—muscle cancer	0.00855	0.0254	CbGeAlD
Acitretin—RARA—tendon—muscle cancer	0.00832	0.0247	CbGeAlD
Acitretin—RXRB—testis—muscle cancer	0.00826	0.0245	CbGeAlD
Acitretin—RARG—vagina—muscle cancer	0.00821	0.0244	CbGeAlD
Acitretin—RARA—bone marrow—muscle cancer	0.00806	0.0239	CbGeAlD
Acitretin—RARG—head—muscle cancer	0.00759	0.0225	CbGeAlD
Acitretin—RARG—testis—muscle cancer	0.00733	0.0218	CbGeAlD
Acitretin—RARA—head—muscle cancer	0.00713	0.0212	CbGeAlD
Acitretin—RARA—testis—muscle cancer	0.00689	0.0205	CbGeAlD
Acitretin—ALB—testis—muscle cancer	0.00389	0.0115	CbGeAlD
Acitretin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—FH—muscle cancer	0.00172	0.063	CbGpPWpGaD
Acitretin—Candida infection—Doxorubicin—muscle cancer	0.00154	0.00242	CcSEcCtD
Acitretin—Oedema—Dactinomycin—muscle cancer	0.00153	0.00241	CcSEcCtD
Acitretin—Infection—Dactinomycin—muscle cancer	0.00152	0.00239	CcSEcCtD
Acitretin—Dry eye—Doxorubicin—muscle cancer	0.00149	0.00234	CcSEcCtD
Acitretin—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00148	0.00232	CcSEcCtD
Acitretin—Oesophagitis—Doxorubicin—muscle cancer	0.00147	0.00231	CcSEcCtD
Acitretin—Anorexia—Dactinomycin—muscle cancer	0.00146	0.00229	CcSEcCtD
Acitretin—Eye disorder—Etoposide—muscle cancer	0.00146	0.00229	CcSEcCtD
Acitretin—Mouth ulceration—Doxorubicin—muscle cancer	0.00146	0.00229	CcSEcCtD
Acitretin—Flushing—Etoposide—muscle cancer	0.00145	0.00227	CcSEcCtD
Acitretin—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00143	0.00225	CcSEcCtD
Acitretin—Myalgia—Vincristine—muscle cancer	0.00143	0.00224	CcSEcCtD
Acitretin—Visual disturbance—Methotrexate—muscle cancer	0.00142	0.00224	CcSEcCtD
Acitretin—Angiopathy—Etoposide—muscle cancer	0.00141	0.00222	CcSEcCtD
Acitretin—Hypertonia—Doxorubicin—muscle cancer	0.00141	0.00222	CcSEcCtD
Acitretin—Immune system disorder—Etoposide—muscle cancer	0.00141	0.00221	CcSEcCtD
Acitretin—Chills—Etoposide—muscle cancer	0.0014	0.0022	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00139	0.00219	CcSEcCtD
Acitretin—Alopecia—Etoposide—muscle cancer	0.00138	0.00217	CcSEcCtD
Acitretin—Cerebrovascular accident—Methotrexate—muscle cancer	0.00138	0.00216	CcSEcCtD
Acitretin—Oedema—Vincristine—muscle cancer	0.00137	0.00215	CcSEcCtD
Acitretin—Infection—Vincristine—muscle cancer	0.00136	0.00213	CcSEcCtD
Acitretin—Osteoarthritis—Methotrexate—muscle cancer	0.00135	0.00212	CcSEcCtD
Acitretin—Diabetes mellitus—Doxorubicin—muscle cancer	0.00134	0.00211	CcSEcCtD
Acitretin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00134	0.0021	CcSEcCtD
Acitretin—Photosensitivity—Doxorubicin—muscle cancer	0.00133	0.00209	CcSEcCtD
Acitretin—Decreased appetite—Dactinomycin—muscle cancer	0.00133	0.00209	CcSEcCtD
Acitretin—Dysgeusia—Etoposide—muscle cancer	0.00133	0.00209	CcSEcCtD
Acitretin—Hyperhidrosis—Vincristine—muscle cancer	0.00132	0.00208	CcSEcCtD
Acitretin—Fatigue—Dactinomycin—muscle cancer	0.00132	0.00207	CcSEcCtD
Acitretin—Back pain—Etoposide—muscle cancer	0.00131	0.00206	CcSEcCtD
Acitretin—Pain—Dactinomycin—muscle cancer	0.00131	0.00206	CcSEcCtD
Acitretin—Vascular purpura—Doxorubicin—muscle cancer	0.00131	0.00205	CcSEcCtD
Acitretin—Muscle spasms—Etoposide—muscle cancer	0.0013	0.00205	CcSEcCtD
Acitretin—Anorexia—Vincristine—muscle cancer	0.0013	0.00205	CcSEcCtD
Acitretin—Eczema—Doxorubicin—muscle cancer	0.0013	0.00204	CcSEcCtD
Acitretin—Eye pain—Doxorubicin—muscle cancer	0.00129	0.00203	CcSEcCtD
Acitretin—Feeling abnormal—Dactinomycin—muscle cancer	0.00126	0.00198	CcSEcCtD
Acitretin—Ill-defined disorder—Etoposide—muscle cancer	0.00126	0.00198	CcSEcCtD
Acitretin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00125	0.00197	CcSEcCtD
Acitretin—Hot flush—Doxorubicin—muscle cancer	0.00125	0.00196	CcSEcCtD
Acitretin—Liver function test abnormal—Methotrexate—muscle cancer	0.00125	0.00196	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00125	0.00196	CcSEcCtD
Acitretin—Increased appetite—Doxorubicin—muscle cancer	0.00124	0.00196	CcSEcCtD
Acitretin—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00124	0.00195	CcSEcCtD
Acitretin—Menopausal symptoms—Doxorubicin—muscle cancer	0.00124	0.00195	CcSEcCtD
Acitretin—Insomnia—Vincristine—muscle cancer	0.00124	0.00194	CcSEcCtD
Acitretin—Paraesthesia—Vincristine—muscle cancer	0.00123	0.00193	CcSEcCtD
Acitretin—Malaise—Etoposide—muscle cancer	0.00122	0.00192	CcSEcCtD
Acitretin—Dermatitis bullous—Doxorubicin—muscle cancer	0.00122	0.00192	CcSEcCtD
Acitretin—Purpura—Doxorubicin—muscle cancer	0.00121	0.00191	CcSEcCtD
Acitretin—Body temperature increased—Dactinomycin—muscle cancer	0.00121	0.0019	CcSEcCtD
Acitretin—Abdominal pain—Dactinomycin—muscle cancer	0.00121	0.0019	CcSEcCtD
Acitretin—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00119	0.00187	CcSEcCtD
Acitretin—Decreased appetite—Vincristine—muscle cancer	0.00119	0.00187	CcSEcCtD
Acitretin—Cough—Etoposide—muscle cancer	0.00118	0.00186	CcSEcCtD
Acitretin—Gastrointestinal disorder—Vincristine—muscle cancer	0.00118	0.00186	CcSEcCtD
Acitretin—Fatigue—Vincristine—muscle cancer	0.00118	0.00185	CcSEcCtD
Acitretin—Constipation—Vincristine—muscle cancer	0.00117	0.00184	CcSEcCtD
Acitretin—Pain—Vincristine—muscle cancer	0.00117	0.00184	CcSEcCtD
Acitretin—Diplopia—Doxorubicin—muscle cancer	0.00117	0.00184	CcSEcCtD
Acitretin—Osteoarthritis—Doxorubicin—muscle cancer	0.00117	0.00184	CcSEcCtD
Acitretin—Chest pain—Etoposide—muscle cancer	0.00115	0.00182	CcSEcCtD
Acitretin—Migraine—Doxorubicin—muscle cancer	0.00115	0.00181	CcSEcCtD
Acitretin—Pancreatitis—Methotrexate—muscle cancer	0.00114	0.0018	CcSEcCtD
Acitretin—Discomfort—Etoposide—muscle cancer	0.00114	0.00179	CcSEcCtD
Acitretin—Hypersensitivity—Dactinomycin—muscle cancer	0.00113	0.00177	CcSEcCtD
Acitretin—Gastrointestinal pain—Vincristine—muscle cancer	0.00112	0.00176	CcSEcCtD
Acitretin—Pancytopenia—Methotrexate—muscle cancer	0.00111	0.00174	CcSEcCtD
Acitretin—Infection—Etoposide—muscle cancer	0.0011	0.00173	CcSEcCtD
Acitretin—Asthenia—Dactinomycin—muscle cancer	0.0011	0.00173	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—muscle cancer	0.00109	0.00172	CcSEcCtD
Acitretin—Dysuria—Methotrexate—muscle cancer	0.00109	0.00171	CcSEcCtD
Acitretin—Abdominal pain—Vincristine—muscle cancer	0.00108	0.0017	CcSEcCtD
Acitretin—Body temperature increased—Vincristine—muscle cancer	0.00108	0.0017	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—muscle cancer	0.00108	0.0017	CcSEcCtD
Acitretin—Skin disorder—Etoposide—muscle cancer	0.00108	0.00169	CcSEcCtD
Acitretin—Erectile dysfunction—Methotrexate—muscle cancer	0.00107	0.00169	CcSEcCtD
Acitretin—Dry skin—Doxorubicin—muscle cancer	0.00107	0.00168	CcSEcCtD
Acitretin—Hyperhidrosis—Etoposide—muscle cancer	0.00107	0.00168	CcSEcCtD
Acitretin—Photosensitivity reaction—Methotrexate—muscle cancer	0.00106	0.00167	CcSEcCtD
Acitretin—Anorexia—Etoposide—muscle cancer	0.00106	0.00166	CcSEcCtD
Acitretin—Diarrhoea—Dactinomycin—muscle cancer	0.00105	0.00165	CcSEcCtD
Acitretin—Depression—Methotrexate—muscle cancer	0.00104	0.00163	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—muscle cancer	0.00103	0.00163	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00103	0.00162	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—muscle cancer	0.00103	0.00162	CcSEcCtD
Acitretin—Stomatitis—Methotrexate—muscle cancer	0.00101	0.00159	CcSEcCtD
Acitretin—Conjunctivitis—Methotrexate—muscle cancer	0.00101	0.00159	CcSEcCtD
Acitretin—Hypersensitivity—Vincristine—muscle cancer	0.00101	0.00158	CcSEcCtD
Acitretin—Paraesthesia—Etoposide—muscle cancer	0.000994	0.00156	CcSEcCtD
Acitretin—Haematuria—Methotrexate—muscle cancer	0.000991	0.00156	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—muscle cancer	0.00099	0.00156	CcSEcCtD
Acitretin—Somnolence—Etoposide—muscle cancer	0.000984	0.00155	CcSEcCtD
Acitretin—Epistaxis—Methotrexate—muscle cancer	0.000981	0.00154	CcSEcCtD
Acitretin—Asthenia—Vincristine—muscle cancer	0.00098	0.00154	CcSEcCtD
Acitretin—Vomiting—Dactinomycin—muscle cancer	0.000972	0.00153	CcSEcCtD
Acitretin—Rash—Dactinomycin—muscle cancer	0.000964	0.00152	CcSEcCtD
Acitretin—Decreased appetite—Etoposide—muscle cancer	0.000962	0.00151	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—muscle cancer	0.000959	0.00151	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000956	0.0015	CcSEcCtD
Acitretin—RXRG—Regulation of Androgen receptor activity—FOXO1—muscle cancer	0.000954	0.035	CbGpPWpGaD
Acitretin—Fatigue—Etoposide—muscle cancer	0.000954	0.0015	CcSEcCtD
Acitretin—Constipation—Etoposide—muscle cancer	0.000947	0.00149	CcSEcCtD
Acitretin—Pain—Etoposide—muscle cancer	0.000947	0.00149	CcSEcCtD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—FOXO1—muscle cancer	0.000945	0.0347	CbGpPWpGaD
Acitretin—Dysuria—Doxorubicin—muscle cancer	0.000944	0.00148	CcSEcCtD
Acitretin—Haemoglobin—Methotrexate—muscle cancer	0.000938	0.00148	CcSEcCtD
Acitretin—Diarrhoea—Vincristine—muscle cancer	0.000935	0.00147	CcSEcCtD
Acitretin—Hepatitis—Methotrexate—muscle cancer	0.000933	0.00147	CcSEcCtD
Acitretin—Haemorrhage—Methotrexate—muscle cancer	0.000933	0.00147	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—HMGA1—muscle cancer	0.000927	0.034	CbGpPWpGaD
Acitretin—Pharyngitis—Methotrexate—muscle cancer	0.000926	0.00146	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000922	0.00145	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—muscle cancer	0.000919	0.00144	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—muscle cancer	0.000913	0.00144	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—muscle cancer	0.000912	0.00143	CcSEcCtD
Acitretin—Nausea—Dactinomycin—muscle cancer	0.000909	0.00143	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—muscle cancer	0.000905	0.00142	CcSEcCtD
Acitretin—Dizziness—Vincristine—muscle cancer	0.000904	0.00142	CcSEcCtD
Acitretin—Visual impairment—Methotrexate—muscle cancer	0.000899	0.00141	CcSEcCtD
Acitretin—RXRB—Regulation of Androgen receptor activity—FOXO1—muscle cancer	0.000897	0.0329	CbGpPWpGaD
Acitretin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000882	0.00139	CcSEcCtD
Acitretin—Urticaria—Etoposide—muscle cancer	0.000879	0.00138	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—muscle cancer	0.000878	0.00138	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—muscle cancer	0.000878	0.00138	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—muscle cancer	0.000875	0.00138	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—muscle cancer	0.000875	0.00138	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—muscle cancer	0.000875	0.00138	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—muscle cancer	0.000875	0.00138	CcSEcCtD
Acitretin—Eye disorder—Methotrexate—muscle cancer	0.000872	0.00137	CcSEcCtD
Acitretin—Tinnitus—Methotrexate—muscle cancer	0.00087	0.00137	CcSEcCtD
Acitretin—Vomiting—Vincristine—muscle cancer	0.000869	0.00137	CcSEcCtD
Acitretin—Rash—Vincristine—muscle cancer	0.000862	0.00135	CcSEcCtD
Acitretin—Dermatitis—Vincristine—muscle cancer	0.000861	0.00135	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—muscle cancer	0.000858	0.00135	CcSEcCtD
Acitretin—Headache—Vincristine—muscle cancer	0.000856	0.00135	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—muscle cancer	0.000849	0.00134	CcSEcCtD
Acitretin—Angiopathy—Methotrexate—muscle cancer	0.000847	0.00133	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—muscle cancer	0.000845	0.00133	CcSEcCtD
Acitretin—Immune system disorder—Methotrexate—muscle cancer	0.000843	0.00133	CcSEcCtD
Acitretin—Chills—Methotrexate—muscle cancer	0.000837	0.00132	CcSEcCtD
Acitretin—Alopecia—Methotrexate—muscle cancer	0.000825	0.0013	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—muscle cancer	0.000816	0.00128	CcSEcCtD
Acitretin—Erythema—Methotrexate—muscle cancer	0.000812	0.00128	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—muscle cancer	0.000812	0.00128	CcSEcCtD
Acitretin—Nausea—Vincristine—muscle cancer	0.000812	0.00128	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—muscle cancer	0.00081	0.00127	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—muscle cancer	0.000808	0.00127	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—muscle cancer	0.000808	0.00127	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000804	0.00126	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—muscle cancer	0.000802	0.00126	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—muscle cancer	0.000796	0.00125	CcSEcCtD
Acitretin—Dysgeusia—Methotrexate—muscle cancer	0.000796	0.00125	CcSEcCtD
Acitretin—Asthenia—Etoposide—muscle cancer	0.000794	0.00125	CcSEcCtD
Acitretin—Back pain—Methotrexate—muscle cancer	0.000786	0.00124	CcSEcCtD
Acitretin—Pruritus—Etoposide—muscle cancer	0.000783	0.00123	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—muscle cancer	0.000779	0.00122	CcSEcCtD
Acitretin—Vision blurred—Methotrexate—muscle cancer	0.000766	0.0012	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—muscle cancer	0.000757	0.00119	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—muscle cancer	0.000755	0.00119	CcSEcCtD
Acitretin—Ill-defined disorder—Methotrexate—muscle cancer	0.000754	0.00119	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—muscle cancer	0.000753	0.00118	CcSEcCtD
Acitretin—Flushing—Doxorubicin—muscle cancer	0.00075	0.00118	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—muscle cancer	0.000733	0.00115	CcSEcCtD
Acitretin—Malaise—Methotrexate—muscle cancer	0.000733	0.00115	CcSEcCtD
Acitretin—Dizziness—Etoposide—muscle cancer	0.000732	0.00115	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—muscle cancer	0.00073	0.00115	CcSEcCtD
Acitretin—Chills—Doxorubicin—muscle cancer	0.000725	0.00114	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—muscle cancer	0.000714	0.00112	CcSEcCtD
Acitretin—Cough—Methotrexate—muscle cancer	0.000709	0.00111	CcSEcCtD
Acitretin—Vomiting—Etoposide—muscle cancer	0.000704	0.00111	CcSEcCtD
Acitretin—Erythema—Doxorubicin—muscle cancer	0.000704	0.00111	CcSEcCtD
Acitretin—RXRG—Adipogenesis—HMGA1—muscle cancer	0.000703	0.0258	CbGpPWpGaD
Acitretin—RXRA—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.0007	0.0257	CbGpPWpGaD
Acitretin—Rash—Etoposide—muscle cancer	0.000698	0.0011	CcSEcCtD
Acitretin—Dermatitis—Etoposide—muscle cancer	0.000697	0.0011	CcSEcCtD
Acitretin—Headache—Etoposide—muscle cancer	0.000693	0.00109	CcSEcCtD
Acitretin—Arthralgia—Methotrexate—muscle cancer	0.000692	0.00109	CcSEcCtD
Acitretin—Chest pain—Methotrexate—muscle cancer	0.000692	0.00109	CcSEcCtD
Acitretin—Myalgia—Methotrexate—muscle cancer	0.000692	0.00109	CcSEcCtD
Acitretin—Tension—Doxorubicin—muscle cancer	0.00069	0.00109	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—muscle cancer	0.000689	0.00108	CcSEcCtD
Acitretin—Discomfort—Methotrexate—muscle cancer	0.000683	0.00107	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—muscle cancer	0.000683	0.00107	CcSEcCtD
Acitretin—Back pain—Doxorubicin—muscle cancer	0.00068	0.00107	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—muscle cancer	0.000676	0.00106	CcSEcCtD
Acitretin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—FH—muscle cancer	0.000667	0.0245	CbGpPWpGaD
Acitretin—Vision blurred—Doxorubicin—muscle cancer	0.000663	0.00104	CcSEcCtD
Acitretin—RARA—Adipogenesis—HMGA1—muscle cancer	0.000661	0.0242	CbGpPWpGaD
Acitretin—Infection—Methotrexate—muscle cancer	0.000659	0.00104	CcSEcCtD
Acitretin—Nausea—Etoposide—muscle cancer	0.000658	0.00103	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000653	0.00103	CcSEcCtD
Acitretin—Skin disorder—Methotrexate—muscle cancer	0.000644	0.00101	CcSEcCtD
Acitretin—Hyperhidrosis—Methotrexate—muscle cancer	0.000641	0.00101	CcSEcCtD
Acitretin—Malaise—Doxorubicin—muscle cancer	0.000634	0.000998	CcSEcCtD
Acitretin—Anorexia—Methotrexate—muscle cancer	0.000632	0.000994	CcSEcCtD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—MED12—muscle cancer	0.000632	0.0232	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.000624	0.0229	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000622	0.0228	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—FOXO1—muscle cancer	0.000614	0.0225	CbGpPWpGaD
Acitretin—Cough—Doxorubicin—muscle cancer	0.000614	0.000965	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000604	0.00095	CcSEcCtD
Acitretin—Insomnia—Methotrexate—muscle cancer	0.0006	0.000943	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—muscle cancer	0.000599	0.000942	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—muscle cancer	0.000599	0.000942	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—muscle cancer	0.000599	0.000942	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—muscle cancer	0.000597	0.000939	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000596	0.0219	CbGpPWpGaD
Acitretin—Paraesthesia—Methotrexate—muscle cancer	0.000595	0.000936	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—muscle cancer	0.000592	0.000931	CcSEcCtD
Acitretin—Somnolence—Methotrexate—muscle cancer	0.000589	0.000927	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—muscle cancer	0.000586	0.000921	CcSEcCtD
Acitretin—Dyspepsia—Methotrexate—muscle cancer	0.000584	0.000918	CcSEcCtD
Acitretin—Decreased appetite—Methotrexate—muscle cancer	0.000576	0.000906	CcSEcCtD
Acitretin—Oedema—Doxorubicin—muscle cancer	0.000574	0.000903	CcSEcCtD
Acitretin—RXRG—Regulation of Androgen receptor activity—MDM2—muscle cancer	0.000573	0.021	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000572	0.0009	CcSEcCtD
Acitretin—Fatigue—Methotrexate—muscle cancer	0.000572	0.000899	CcSEcCtD
Acitretin—Infection—Doxorubicin—muscle cancer	0.00057	0.000897	CcSEcCtD
Acitretin—Pain—Methotrexate—muscle cancer	0.000567	0.000892	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—muscle cancer	0.000558	0.000877	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000555	0.000873	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—muscle cancer	0.000547	0.000861	CcSEcCtD
Acitretin—Feeling abnormal—Methotrexate—muscle cancer	0.000546	0.000859	CcSEcCtD
Acitretin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000542	0.000853	CcSEcCtD
Acitretin—RXRB—Regulation of Androgen receptor activity—MDM2—muscle cancer	0.000538	0.0197	CbGpPWpGaD
Acitretin—Urticaria—Methotrexate—muscle cancer	0.000527	0.000828	CcSEcCtD
Acitretin—Abdominal pain—Methotrexate—muscle cancer	0.000524	0.000824	CcSEcCtD
Acitretin—Body temperature increased—Methotrexate—muscle cancer	0.000524	0.000824	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000523	0.000823	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—muscle cancer	0.000519	0.000817	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—muscle cancer	0.000516	0.000811	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—muscle cancer	0.00051	0.000803	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—muscle cancer	0.000505	0.000795	CcSEcCtD
Acitretin—Decreased appetite—Doxorubicin—muscle cancer	0.000499	0.000785	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000496	0.000779	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—muscle cancer	0.000495	0.000778	CcSEcCtD
Acitretin—Constipation—Doxorubicin—muscle cancer	0.000491	0.000772	CcSEcCtD
Acitretin—Pain—Doxorubicin—muscle cancer	0.000491	0.000772	CcSEcCtD
Acitretin—Hypersensitivity—Methotrexate—muscle cancer	0.000489	0.000768	CcSEcCtD
Acitretin—Asthenia—Methotrexate—muscle cancer	0.000476	0.000748	CcSEcCtD
Acitretin—RXRA—PPARA activates gene expression—MED12—muscle cancer	0.000475	0.0174	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—muscle cancer	0.000473	0.000744	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00047	0.000738	CcSEcCtD
Acitretin—Pruritus—Methotrexate—muscle cancer	0.000469	0.000738	CcSEcCtD
Acitretin—RXRA—Regulation of Androgen receptor activity—FOXO1—muscle cancer	0.000468	0.0172	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—FOXO1—muscle cancer	0.000466	0.0171	CbGpPWpGaD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.000465	0.0171	CbGpPWpGaD
Acitretin—Urticaria—Doxorubicin—muscle cancer	0.000456	0.000717	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000454	0.0167	CbGpPWpGaD
Acitretin—Body temperature increased—Doxorubicin—muscle cancer	0.000454	0.000714	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—muscle cancer	0.000454	0.000714	CcSEcCtD
Acitretin—Diarrhoea—Methotrexate—muscle cancer	0.000454	0.000713	CcSEcCtD
Acitretin—Dizziness—Methotrexate—muscle cancer	0.000438	0.000689	CcSEcCtD
Acitretin—RARA—Adipogenesis—FOXO1—muscle cancer	0.000438	0.0161	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000436	0.016	CbGpPWpGaD
Acitretin—Hypersensitivity—Doxorubicin—muscle cancer	0.000423	0.000665	CcSEcCtD
Acitretin—Vomiting—Methotrexate—muscle cancer	0.000422	0.000663	CcSEcCtD
Acitretin—Rash—Methotrexate—muscle cancer	0.000418	0.000657	CcSEcCtD
Acitretin—Dermatitis—Methotrexate—muscle cancer	0.000418	0.000657	CcSEcCtD
Acitretin—Headache—Methotrexate—muscle cancer	0.000415	0.000653	CcSEcCtD
Acitretin—Asthenia—Doxorubicin—muscle cancer	0.000412	0.000648	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—muscle cancer	0.000406	0.000639	CcSEcCtD
Acitretin—Nausea—Methotrexate—muscle cancer	0.000394	0.000619	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—muscle cancer	0.000393	0.000618	CcSEcCtD
Acitretin—RXRA—Developmental Biology—MYF6—muscle cancer	0.000392	0.0144	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MYF5—muscle cancer	0.000392	0.0144	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—muscle cancer	0.00038	0.000597	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—muscle cancer	0.000365	0.000574	CcSEcCtD
Acitretin—Rash—Doxorubicin—muscle cancer	0.000362	0.000569	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—muscle cancer	0.000362	0.000569	CcSEcCtD
Acitretin—Headache—Doxorubicin—muscle cancer	0.00036	0.000566	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	0.000358	0.0131	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KIDINS220—muscle cancer	0.000345	0.0126	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—HMGA1—muscle cancer	0.000344	0.0126	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—muscle cancer	0.000341	0.000536	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—MED12—muscle cancer	0.000339	0.0124	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.00032	0.0117	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000311	0.0114	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MED12—muscle cancer	0.00031	0.0114	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MED12—muscle cancer	0.000304	0.0111	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MED12—muscle cancer	0.000291	0.0107	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MED12—muscle cancer	0.000291	0.0107	CbGpPWpGaD
Acitretin—RXRA—Regulation of Androgen receptor activity—MDM2—muscle cancer	0.000281	0.0103	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—FH—muscle cancer	0.000271	0.00993	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MYOG—muscle cancer	0.000253	0.00927	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—FOXO1—muscle cancer	0.000228	0.00837	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000227	0.00833	CbGpPWpGaD
Acitretin—RBP1—Disease—ENO2—muscle cancer	0.000204	0.00749	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000201	0.00739	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000194	0.00712	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000193	0.00708	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000186	0.00683	CbGpPWpGaD
Acitretin—RBP1—Disease—HMGA1—muscle cancer	0.000186	0.00681	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—IGF2—muscle cancer	0.000167	0.00612	CbGpPWpGaD
Acitretin—RBP1—Disease—FOXO4—muscle cancer	0.000167	0.00611	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MED12—muscle cancer	0.000163	0.00598	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.000159	0.00583	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MYOD1—muscle cancer	0.000156	0.00573	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—MED12—muscle cancer	0.000153	0.00561	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000153	0.00561	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MED12—muscle cancer	0.000152	0.00557	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MED12—muscle cancer	0.000149	0.00547	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000147	0.00538	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MED12—muscle cancer	0.000146	0.00536	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MED12—muscle cancer	0.000143	0.00524	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MED12—muscle cancer	0.00014	0.00514	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MED12—muscle cancer	0.00014	0.00514	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ENO2—muscle cancer	0.000139	0.00512	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTCH1—muscle cancer	0.000136	0.00497	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000128	0.00468	CbGpPWpGaD
Acitretin—RBP1—Disease—FOXO1—muscle cancer	0.000123	0.00451	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FOXO4—muscle cancer	0.000117	0.00428	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000116	0.00424	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CNR1—muscle cancer	0.000114	0.0042	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000111	0.00406	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000101	0.00369	CbGpPWpGaD
Acitretin—RXRA—Metabolism—FH—muscle cancer	0.000101	0.00369	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	9.7e-05	0.00356	CbGpPWpGaD
Acitretin—RBP1—Disease—KIT—muscle cancer	9.37e-05	0.00344	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IGF2—muscle cancer	9.36e-05	0.00343	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FOXO1—muscle cancer	8.61e-05	0.00316	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	8.23e-05	0.00302	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—FOXO1—muscle cancer	7.84e-05	0.00288	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ANGPT2—muscle cancer	7.84e-05	0.00288	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.64e-05	0.0028	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	7.4e-05	0.00271	CbGpPWpGaD
Acitretin—RBP1—Disease—MDM2—muscle cancer	7.38e-05	0.00271	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MED12—muscle cancer	7.31e-05	0.00268	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—muscle cancer	7.12e-05	0.00261	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—muscle cancer	6.99e-05	0.00256	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	6.66e-05	0.00244	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KIT—muscle cancer	6.56e-05	0.00241	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—muscle cancer	6.16e-05	0.00226	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.82e-05	0.00213	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.77e-05	0.00212	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MED12—muscle cancer	5.68e-05	0.00208	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO2—muscle cancer	5.18e-05	0.0019	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MDM2—muscle cancer	5.17e-05	0.0019	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—muscle cancer	4.86e-05	0.00178	CbGpPWpGaD
Acitretin—ALB—Metabolism—FH—muscle cancer	4.59e-05	0.00168	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.05e-05	0.00149	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—muscle cancer	3.93e-05	0.00144	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IGF2—muscle cancer	3.81e-05	0.0014	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—muscle cancer	3.57e-05	0.00131	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	3.1e-05	0.00114	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—muscle cancer	2.97e-05	0.00109	CbGpPWpGaD
Acitretin—ALB—Metabolism—MED12—muscle cancer	2.59e-05	0.00095	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—muscle cancer	2.36e-05	0.000867	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.85e-05	0.000678	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—muscle cancer	1.8e-05	0.000662	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—muscle cancer	1.6e-05	0.000586	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—muscle cancer	1.21e-05	0.000443	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—muscle cancer	8.23e-06	0.000302	CbGpPWpGaD
